Summary
The effect of low dose prednisone on calcium and bone metabolism was evaluated in 8 healthy, young, male volunteers. Sodium and calcium intake were kept stable during the whole study period of 7 weeks. Week 0 was the baseline period; during week 1, 3 and 5 prednisone (10 mg/day) was given, during week 3 together with 500 mg elementary calcium and during week 5 with 4000 IU vitamin D on alternate days. During week 2, 4 and 6 no medication was given. No changes occurred in fasting urinary excretion of calcium or hydroxyproline, nor in serum levels of alkaline phosphatase, 25-Vitamin D, PTH, creatinine and inorganic phosphorus. A rapid decrease of serum osteocalcin during prednisone intake was found (p<0.01). This dip also occurred during prednisone and vitamin D treatment, but did not occur when calcium was added to prednisone, although the baseline value was lower at the start of combined treatment with prednisone and calcium. Serum calcium decreased during prednisone (p<0.05), but when prednisone was given together with calcium, an increase of serum calcium was found. (p<0.05).
It is concluded that 10 mg prednisone/day decreases bone formation, as shown by its effect on osteocalcin, while no influence is seen on bone resorption. Thus, prednisone, even when used in low doses, influences bone metabolism by uncoupling bone formation (decreased) and bone resorption (unchanged). These data suggest that the Cs-associated decrease in serum osteocalcin and in serum calcium does not occur during calcium suppletion.
Similar content being viewed by others
References
Weiss, M.M., Corticosteroids in rheumatoid arthritis. Semin Arthritis Rheum 1989, 19, 9–21.
Barnes, P.J. A new approach to the treatment of asthma. New Engl J Med 1989, 321, 1517–1527.
Caldwell, J.R., Furst, D. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Sem Arthritis Rheum 1991, 21, 1–11.
Dyckman, T.R., Gluck, O.S., Murphy, W.A., Hahn, T.J., Hahn, B.H. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985, 28, 361–368.
Ruegsegger, P., Medici, T.C., Anliker, M. Corticosteroid-induced bone loss. A longitudinal study in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983, 25, 615–620.
Adinoff, A.D., Hollister, J.R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983, 309, 265–268.
Hahn, T.J., Halstead, L.R., Teitelbaum, S.L. Hahn, B.H. Altered mineral metabolism in glucocorticoid-induced osteopenia. J Clin Invest 1979, 64, 655–665.
Klein, R.G., Arnaud, S.B., Gallagher, J.C., DeLuca, H.F., Riggs, B.L. Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 1977, 60, 253–259.
Suzuki, Y., Ichikawa, Y., Saito, E., Homma, M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983, 32, 151–156.
Jee, W.S.S., Park, H.Z., Roberts, W.E., Kenner, G.H. Corticosteroid and bone. Am J Anat 1970, 29, 477.
Dietrich, J.W., Canalis, E.M., Maine, D.M., Raisz, G. Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 1979, 104, 715–721.
Lukert, B.P., Raisz, L.G. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990, 112, 352–364.
Reid, I.R. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinology 1989, 30, 83–103.
Silverman, S.L. Management of corticosteroid-induced osteoporosis: a clinician's perspective. Calcif Tissue Int 1992, 50, 101–103.
Garton, M.J., Reid, D.M., Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Arthritis Rheum 1993, 36, 222–227.
Laan, R.F.J.M., van Riel, P.L.C.M., van Erning, L.J.Th.O., Lemmens, J.A.M., van Ruijs, S.H.J., van de Putte, L.B.A. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheum 1992, 31, 91–96.
Sambrook, P.N., Eisman, J.A., Yeates, M.G., Pocock, N.A. Eberl, S., Champion, G.D. Osteoporosis in rheumatoid arthritis: safety of low dose corticoids. Ann of Rheum Dis 1986, 45, 950–953.
Sambrook, P.N., Cohen, M.L., Eisman, J.A., Pocock, N.A., Champion, G.D., Yeates, M.G. Effects of low dose corticosterois on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989, 48, 535–538.
Leboff, M.S., Wade, J.P., Maclowiak, S., Fuleihan, G.E.H., Zangari, M., Liang, M.H. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol 1991, 18, 339–344.
Bijlsma, J.W.J. Bone metabolism in patients with rheumatoid arthritis. Clin Rheumatol 1988, 7, 16–23.
Laan, R.F.J.M., van Riel, P.L.C.M., van de Putte, L.B.A. Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992, 826–832.
Brown, J.P., Malaval, L., Chapuy, M.C., Delmas, P.D., Edouard, C., Meunier, P.J. Serum Bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984, 5, 1091–1093.
Lems, W.F., Jacobs, J.W.G., van den Brink, H.R., van Rijn, H.J.M., Bijlsma, J.W.J. Transient decrease in osteocalcin and markers of collagen type 1 formation during corticosteroid pulse therapy. Br J Rheum 1993, 32, 787–790.
Kotowicz, M.A., Hall, S., Hunder, G.G., Cedel, S.L., Mann, K.G., Riggs, B.L. Relationship of glucocorticoid dosage to serum bone GLA-protein concentration in patients with rheumatologic disorders. Arthritis Rheum 1990, 10, 1487–1492.
Adachi, J.D. Markers of bone turnover in rheumatoid arthritis. J Rheumatol 1991, 18, 119–120.
Godschalk, M., Downs, R. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Min Res 1988, 3, 113–115.
Mitchell, D.R., Jackson, T.W., Lyles, K.W. Effects of short-term administration of glucocorticoids on bone metabolism in healthy elderly men. J Am Geriatr Soc 39, 1179–1182.
Prummel, M.F., Wiersinga, W.M., Lips, P., Sanders, G.T.B., Sauerwein, H.P. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991, 72, 382–386.
Caniggia, A., Nuti, R., Lore, F., Vattimo, A. Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochemistry 1981, 15, 153–161.
hahn, T.J., Halstead, L.R., Bran, D.T. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolic concentrations in man. J Clin Endocrinology Metab 1981, 52, 111–115.
Chesney, R.W., Mazess, R.B., Hamstra, A.J., DeLuca, H.F. Reduction of serum- 1,25 dihydroxyvitamin D3 in children receiving glucocorticoids. Lancet 1978, ii, 1123–1125.
Fucik, R.F., Kukreja, S.C., Hargis, G.K., Bowser, E.N., Henderson, W.J., Williams, G.A. Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 1975, 40, 152–156.
Seeman, E., Kumar, R., Hunder, G.G., Scott, M., Heath, H., III, Riggs, B.L. Production, degradation and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest 1980, 66, 664–669.
Reid, I.R., Ibbertson, H.K. Calcium supplements in the prevention of steroid induced osteoporosis. Am J Clin Nutr 1986, 44, 287–290.
Bijlsma, J.W.J., Raymakers, J.A., Mosch, C., Hoekstra, A., Derksen, R.W.H.M., Baart de la Faille H, Duursma, S.A. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol 1988, 6, 113–119.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lems, W.F., Jacobs, J.W.G., Van Rijn, H.J.M. et al. Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers. Clin Rheumatol 14, 420–424 (1995). https://doi.org/10.1007/BF02207675
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02207675